Clinical Trials Search at Vanderbilt-Ingram Cancer Center

ION-682884-CS2 - A Phase 3 Global, Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Efficacy and Safety of ION-682884 in Patients with Transthyretin-Mediated Amyloid Cardiomyopathy (ATTR CM)

Disease Sites:

Not Available

Therapies:

Not Available

Drugs:

Not Available

Principal Investigator(s):

Hung, Rebecca

Participating Institutions:

Vanderbilt University

Open Date:

08-27-2020

Trial Type:

Other

Protocol ID:

CRE-CHF0006

Related Internal Documents:

View Internal Documents

Eligibility

Ages Eligible for Study:

Not Available

Genders Eligible for Study:

Not Available

Accepts Healthy Volunteers?:

Not Available